Background: The way in which patients with transient ischemic attack (TIA) are investigated and treated varies substantially worldwide. There are no data on the management and outcome of TIA patients admitted to a stroke unit. We assessed to what extent rapid management of TIA patients admitted to a stroke unit led to specific treatments which can prevent stroke and evaluated the early risk and predictors of stroke in these patients. Methods: From January 2003 to November 2005, 203 consecutive patients with a recent (<48 h) TIA were admitted to our stroke unit. All patients had a diffusion-weighted imaging (DWI) on admission, a standardized etiological workup, and were followed up to 3 months. Results: The median (interquartile range) time from TIA onset to admission to the stroke unit was 12 h (5–25). DWI revealed acute lesions in 64 patients (32%). Of the 203 patients, 147 (72%) were treated by antiplatelet therapy and 56 (28%) with high doses of heparin, soon after their admission. In addition, 7 patients (3%) had a carotid revascularization. The risk of stroke was 2.5% (95% CI, 0.3–4.7) at 1 week, and 3.5% (1.0–6.1) at 3 months. In multivariate analysis, a score ≧5 at the previously validated ABCD score (HR = 5.0; 1.0–25.8; p = 0.06) and the presence of DWI abnormalities (HR = 10.3; 1.2–86.7; p = 0.03) were independent predictors of stroke at 3 months. Conclusion: Early management of TIA in a stroke unit leads to specific treatments in a significant proportion of cases. The presence of acute lesions on DWI and the ABCD score predict the 3-month risk of stroke after TIA.

1.
Johnston SC, Gress DR, Browner WS, Sidney S: Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901–2906.
2.
Lovett J, Dennis M, Sandercock PAG, Bamford J, Warlow CP, Rothwell PM: The very early risk of stroke following a TIA. Stroke 2003;34:e138–e140.
3.
Coull A, Lovett JK, Rothwell PM, Oxford Vascular Study: Early risk of stroke after a TIA or minor stroke in a population-based incidence study. BMJ 2004;328:326–328.
4.
Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP: The high risk of stroke immediately after transient ischemic attack. A population-based study. Neurology 2004;62:2015–2020.
5.
Lisabeth LD, Ireland JK, Risser JM, Brown DL, Smith MA, Garcia NM, Morgenstern LB: Stroke risk after transcient ischemic attacks in a population-based setting. Stroke 2004;35:1842–1846.
6.
Correia M, Silva MR, Magalhaes R, Guimaraes L, Silva C: Transient ischemic attacks in rural and urban northern Portugal. Incidence and short-term prognosis. Stroke 2006;37:50–55.
7.
Wolf PA, Clagett GP, Easton JD, Goldstein LB, Gorelick PB, Kelly-Hayes M, Sacco RL, Whisnant JP: Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 1999;30:1991–1994.
8.
Intercollegiate Working Party for Stroke: National Clinical Guidelines for Stroke. London, Royal College of Physicians, 2000.
9.
Department of Health: National Service Framework for Older People. London, Department of Health, 2001. www.doh.gov.uk/nsf.
10.
Albucher JF, Martel P, Mas JL: Clinical practice guidelines: diagnosis and immediate management of transient ischemic attacks in adults. Cerebrovasc Dis 2005;20:220–225.
11.
Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21:637–676.
12.
Lamy C, Oppenheim C, Calvet D, Domigo V, Naggara O, Meder JF, Mas JL: Diffusion-weighted MR imaging in transient ischaemic attacks. Eur Radiol 2006;16:1090–1095.
13.
Oppenheim C, Lamy C, Touzé E, Calvet D, Hamon M, Mas JL, Meder JF: Do transient ischemic attacks with diffusion abnormalities correspond to brain infarctions? Am J Neuroradiol 2006;27:1782–1787.
14.
Adams HP, Bendixen BH, Kapelle LJ, Biller J, Love BB, Gordon DL, Marsh EE; TOAST investigators: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993;24:35–41.
15.
Kappelle LJ, van Latum JC, Koudstaal PJ, van Gijn J: Transcient ischaemic attacks and small-vessel disease. Lancet 1991;337:339–341.
16.
Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JNE, Warlow CP, Mehta Z: A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 2005;366:29–39.
17.
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997;349:1569–1581.
18.
CAST: randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997;349:1641–1649.
19.
Hart RG, Pearce LA, Koudstaal PJ: Transient ischemic attacks in patients with atrial fibrillation. Implications for secondary prevention: the European atrial fibrillation trial and stroke prevention in atrial fibrillation III trial. Stroke 2004;35:948–951.
20.
Lyrer P, Engelter S: Antithrombotic drugs for carotid artery dissection. Stroke 2004;35:613–614.
21.
Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM: Effect of endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and to the timing of surgery. Lancet 2004;363:915–924.
22.
Nguyen-Huynh MN, Johnston SC: Is hospitalization after TIA cost-effective on the basis of treatment with tPA? Neurology 2005;65:1799–1801.
23.
Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhem M, Hamilton S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDSrt-PA stroke trials. Lancet 2004;363:768–774.
24.
Rothwell PM, Buchan A, Johnston SC: Recent advances in management of transient ischaemic attacks or minor strokes. Lancet Neurol 2006;5:323–331.
25.
Gladstone DJ, Kapral MK, Fang J, Laupacis A, Tu JC : Management and outcome of transient ischemic attacks in Ontario. CMAJ 2004;170:1099–1104.
26.
Kleindorfer D, Panagos P, Pancioli A, Khoury J, Kissela B, Woo D, Schneider A, Alwell K, Jauch E, Miller R, Moomaw C, Shukla R, Broderick JP: Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 2005;36:720–724.
27.
Purroy F, Montaner J, Rovira A, Delgado P, Quintana M, Alvarez-Sabin J: Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute lesions. Stroke 2004;35:2313–2319.
28.
Coutts SB, Simon JE, Eliasziw M, Sohn CH, Hill MD, Barber PA, Palumbo V, Kennedy J, Roy J, Gagnon A, Scott JN, Buchan AM, Demchuck AM: Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 2005;57:848–854.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.